05 July 2019 | News
Current regulatory capacity and enforcement are insufficient in most developing countries
image credit- shuttershock.com
Despite global progress, serious problems with health product quality and safety persist, particularly in lower- and middle-income countries. These problems threaten the health of people every day and waste resources. Quality and safety of medicines, vaccines and other products are compromised when manufacturers, whether by accident or intent, produce substandard products, when the supply chain allows unsafe medical products through, and when systems (usually due to lack of resources) are too slow to respond to adverse events.
As a reuslt, the World Health Organistation (WHO) has launched a five-year plan ‘Delivering Quality-assured Medical Products for All 2019–2023’.
The plan outlines work and activities to reach four main objectives:
While WHO has worked to improve the quality and safety of health products for many years, this is the first time it is aligning goals and activities with global partners (Bill and Melinda Gates Foundation, UNITAID, The Global Fund to Fight AIDS, TB and Malaria, GAVI and UNICEF) to ensure full coordination and work towards a common goal – to deliver a safe and quality-assured supply of medicines, vaccines, medical devices and other health products for all populations.